HWAM
ENTA icon

Hennion & Walsh Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,689
Closed -$239K – 860
2024
Q1 		$239K Sell
13,689
-2,062
-13% -$27.3K 0.01% 755
2023
Q4 		$148K Sell
15,751
-12,283
-44% -$114K 0.01% 793
2023
Q3 		$313K Sell
28,034
-2,380
-8% -$38.3K 0.02% 637
2023
Q2 		$651K Sell
30,414
-165
-0.5% -$4.86K 0.04% 445
2023
Q1 		$1.24M Sell
30,579
-750
-2% -$35.8K 0.08% 317
2022
Q4 		$1.46M Sell
31,329
-38,995
-55% -$1.78M 0.09% 263
2022
Q3 		$3.65M Sell
70,324
-7,096
-9% -$415K 0.24% 108
2022
Q2 		$3.66M Sell
77,420
-27,074
-26% -$1.47M 0.23% 120
2022
Q1 		$7.44M Buy
104,494
+2,430
+2% +$158K 0.4% 59
2021
Q4 		$7.63M Sell
102,064
-18,176
-15% -$1.43M 0.37% 63
2021
Q3 		$6.83M Sell
120,240
-4,140
-3% -$205K 0.36% 62
2021
Q2 		$5.47M Buy
124,380
+10,440
+9% +$511K 0.29% 81
2021
Q1 		$5.62M Buy
+113,940
New +$5.68M 0.34% 73

Other funds holding ENTA

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hennion & Walsh Asset Management's ENTA Position: Q2 2024 in Review

Hennion & Walsh Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2024, closing a stake of 13,689 shares — an estimated $239K sold.

Hennion & Walsh Asset Management first reported a position in ENTA in Q1 2021 and held it in 13 quarters. The position peaked at $7.63M in Q4 2021. 100 funds tracked by Wall St. Rank hold ENTA as of Q2 2024.

  • Hennion & Walsh Asset Management reported no remaining Enanta Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 13,689 Enanta Pharmaceuticals shares in Q2 2024, an estimated $239K.
  • Hennion & Walsh Asset Management first reported a position in Enanta Pharmaceuticals in Q1 2021 and held it in 13 quarters.
  • Hennion & Walsh Asset Management's Enanta Pharmaceuticals position peaked at $7.63M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2024, filed 19 Jul 2024.